Man Group
RAIN

Man Group’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Man Group’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-16,259
Closed -$150K – 1941
2022
Q4 		$130K Buy
+16,259
New +$102K ﹤0.01% 1861

Other funds holding RAIN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Man Group's RAIN Position: Q1 2023 in Review

Man Group sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2023, closing a stake of 16,259 shares — an estimated $150K sold.

Man Group first reported a position in RAIN in Q4 2022 and held it in 1 quarter. The position peaked at $130K in Q4 2022. 59 funds tracked by Wall St. Rank hold RAIN as of Q1 2023.

  • Man Group reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Man Group sold 16,259 Rain Oncology Inc. Common Stock shares in Q1 2023, an estimated $150K.
  • Man Group first reported a position in Rain Oncology Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Man Group's Rain Oncology Inc. Common Stock position peaked at $130K in Q4 2022.
  • 59 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2023.

Based on Man Group's 13F filing for Q1 2023, filed 15 May 2023.